[O2Micro Reports Second Quarter Results 2 GEORGE TOWN, Grandyman, Aug. 1, 2012 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2012 2 O GAAP net loss was $10.9 million in Q2 2012. Thismpares to GAAP netome of $44,000 in the first quarter of 2012 and GAAP netome of $3.0 million]
[China Sunergy Announces to Hold Annual General Meeting on September 5, 2012 and Changes to Board of Directors NANJING, China, August 6, 2012 - China Sunergy Co., Ltd. (Nasdaq: CSUN) (“China Sunergy” or “the Company”), a specialized solar cell and module manufacturer, today announced that Holders of record of ordinary shares of the Company at the close of business on] [CHINA SUNERGY CO., LTD NOTICE OF ANNUAL GENERAL MEETING To be held on September 5, 2012 NOTICE IS HEREBY GIVEN that an annual general meeting of China Sunergy Co., Ltd. (the “Company”) will be held at No. 123, Focheng West Road, Jiangning Economic & Technical Development Zone, Nanjing, Jiangsu 211100, the People’s Republic of China on September 5, 2012 at] [CHINA ( SUNERGY Incorporated in the Cayman Islands with limited liability) Proxy for Annual General Meeting (or any adjournment thereof) to be held on September 5, 2012 Introduction This Proxy is furnished in connection with the solicitation by the Board of Directors of China Sunergy Co., Ltd., a Cayman Islands company (the “Company”), of proxies from the holders of the] [CHINA SUNERGY CO., LTD. TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS (“ADRs”) REPRESENTING ORDINARY SHARES OF CHINA SUNERGY CO., LTD. Please refer to the reverse side of this card for the Resolutions to be voted at the Meeting. FOLD AND DETACH HERE ORDINARY RESOLUTIONS FOR AGAINST FOR AGAINST Res. 1 £ £ Res. 4 £ £ Res. 2 £]
[BIOSTAR PHARMACEUTICALS, RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTARTLES OF ITS GELPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases andnditions, today announced that on July 30, 2012, after a thorough]
[August 6, 2012 VIA EDGAR Kathleen Collins, Accounting Branch Chief Laura Veator, Staff Accountant Division of Corporation Finance 100 F Street, N.E. Re: Ctrip.com International, Ltd. (the Company) Form 20-F for the Fiscal Year Ended December 31, 2011 Filed on March 30, 2012 (the 2011 Form 20-F) (File No. 001-33853) Dear Ms. Collins and Ms. Veator: * * * Form]
[BIOSTAR PHARMACEUTICALS, RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTARTLES OF ITS GELPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases andnditions, today announced that on July 30, 2012, after a thorough]
[August 6, 2012 VIA EDGAR Kathleen Collins, Accounting Branch Chief Laura Veator, Staff Accountant Division of Corporation Finance 100 F Street, N.E. Re: Ctrip.com International, Ltd. (the Company) Form 20-F for the Fiscal Year Ended December 31, 2011 Filed on March 30, 2012 (the 2011 Form 20-F) (File No. 001-33853) Dear Ms. Collins and Ms. Veator: * * * Form]
